PAI1 Antikörper (HRP)
Kurzübersicht für PAI1 Antikörper (HRP) (ABIN7536756)
Target
Alle PAI1 (SERPINE1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- PAI-1 - Plasminogen Activator Inhibitor type 1 Polyclonal Antibody - HRP Conjugated
-
Spezifität
- Human Plasminogen Activator Inhibitor-1, PAI-1
-
Aufreinigung
- Fractionation of IgG from antiserum
-
Immunogen
- Recombinant Plasminogen Activator Inhibitor-1 (PAI-1) prepared from bacterial extracts
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Immunoblot 5 μg/mL, ELISA detecting 10 μg/mL
-
Kommentare
-
Whole IgG is a base level product and refers to IgG antibodies purified from antiserum using multiple precipitation and dialysis steps. The purity of the IgG is typically 90% and is provided in a solution of HEPES buffered saline containing 50% glycerol (v/v). The titre is essentially the same as the starting antiserum and each vial typically contains the amount of IgG recovered from one millilitre of antiserum. This level of product is generally intended for use in applications such as immunoprecipitation, immunoelectrophoresis, immuno-depletion and activity neutralization assays.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Rekonstitution
- Allow product to warm to room temperature and gently mix before use
-
Konzentration
- 2 mg/mL
-
Buffer
- A buffered stabilizer solution containing 50 % (v/v) glycerol
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store between -10°C and -20°C
-
-
- PAI1 (SERPINE1) (Plasminogen Activator Inhibitor 1 (SERPINE1))
-
Andere Bezeichnung
- PAI-1
-
Pathways
- p53 Signalweg, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagie, Smooth Muscle Cell Migration
Target
-